A Theoretical And Clinical Research About Malignant Tumor Treated By Resolving Phlegm

Objective: Thorugh theoretical and clinical investigation of demonstrate thefeasibility and scientificity of malignant tumor treated variation from phlegm syndrome.Methods: Clinical treatment group were treated with Strengthening the spleen andreducing phlegm tonic prescription combined with GP regimen chemotherapy, the controlgroup only receive GP chemotherapy. After two cycles, observe the main disease recoveryrate, efficacy, tumor markers changes, qualities of life, adverse reaction rates.Look upsome literature about phlegm, study the relatition between phlegm and cancer,Hold thepoint about treatment variation from phlegm of cancer. Results:The main symptomsimprovement rate, quality of life KPS score, toxicity the effects were compared with thecontrol group were significant differences (P<0.05); term clinical efficacy and reduce thetumor markers CEA and Cyfra21-one aspect in the control group, but no significantdifference (P>0.05). Literature review to summarize the phlegm syndrome andtumor-related research, the basis and point of view of the malignant tumor from the sputumtreatment based on. Conclusion: Spleen Paste combined with chemotherapy to improvethe main symptoms, improve quality of life and reduce the chemotherapy drug toxicityadvantage. Point of view of cancer and relevance of the research base Phegm pneuma-The phlegm syndrome-tumor, the sputum of a multi-level point of view, cancerpathogenesis knot Spleen sputum mainly by correcting the treatment of spleen deficiencyfrom the fundamental principle of Phlegm play a role in consumer product anti-cancer.